{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:24:00Z","timestamp":1790760240495,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Australian National Health","award":["1113842"],"award-info":[{"award-number":["1113842"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbadis.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T12:32:19Z","timestamp":1533904339000},"page":"993-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Animal models for hepatocellular carcinoma"],"prefix":"10.1016","volume":"1865","author":[{"given":"Hui Emma","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Gorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.08.009_bb0005","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0015","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2017.05.001","article-title":"Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: patient-focused outcome results from the randomised phase III REACH study","volume":"81","author":"Chau","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2016.03.047","article-title":"Hepatocellular carcinoma: mouse models and the potential roles of proteases","volume":"387","author":"Henderson","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"EASL","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo","volume":"34","author":"Williams","year":"2013","journal-title":"Endocr. Rev."},{"issue":"Suppl. 4","key":"10.1016\/j.bbadis.2018.08.009_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0050","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0055","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ng1481","article-title":"Application of comparative functional genomics to identify best-fit mouse models to study human cancer","volume":"36","author":"Lee","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/hep.24133","article-title":"Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice","volume":"53","author":"Aleksic","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jss.2007.12.748","article-title":"Mouse model of diethylnitrosamine-induced gastric cancer","volume":"148","author":"Binato","year":"2008","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","article-title":"N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation","volume":"71","author":"Verna","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0075","first-page":"1625","article-title":"Age- and sex-associated diethylnitrosamine dealkylation activity of the mouse liver and hepatocarcinogenesis","volume":"33","author":"Rao","year":"1973","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0080","first-page":"4253","article-title":"Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse","volume":"43","author":"Vesselinovitch","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0085","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41598-018-19492-x","article-title":"Molecular characterization of the grape seeds extract's effect against chemically induced liver cancer: in vivo and in vitro analyses","volume":"8","author":"Hamza","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0090","doi-asserted-by":"crossref","first-page":"56095","DOI":"10.18632\/oncotarget.10893","article-title":"Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-kappaB activation","volume":"8","author":"Gehrke","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jceh.2015.07.205","article-title":"Plasma lipid profiling in a rat model of hepatocellular carcinoma: potential modulation through quinolone administration","volume":"5","author":"Shariff","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0100","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.3892\/ol.2017.6800","article-title":"Combined use of alcohol in conventional chemical-induced mouse liver cancer model improves the simulation of clinical characteristics of human hepatocellular carcinoma","volume":"14","author":"Xin","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.etp.2014.03.003","article-title":"Establishment of a liver fibrosis model in cynomolgus monkeys","volume":"66","author":"Ding","year":"2014","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10590500701569398","article-title":"Postulated carbon tetrachloride mode of action: a review","volume":"25","author":"Manibusan","year":"2007","journal-title":"J. Environ. Sci. Health C"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0300-483X(01)00429-2","article-title":"Carbon tetrachloride-induced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: role of antioxidants","volume":"165","author":"Sheweita","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)65594-0","article-title":"Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride","volume":"153","author":"Shi","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0130","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-230X-10-79","article-title":"Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor","volume":"10","author":"Fujii","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41419-018-0267-9","article-title":"The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K\/Akt pathway activation","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0145","doi-asserted-by":"crossref","DOI":"10.3727\/105221618X15205148413587","article-title":"Hepatocyte Wnts are dispensable during diethylnitrosamine and carbon tetrachloride-induced injury and hepatocellular cancer","author":"Preziosi","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41598-017-00671-1","article-title":"TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice","volume":"7","author":"Thiele","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0155","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/labinvest.2010.139","article-title":"Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity","volume":"90","author":"Yang","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0160","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/tx3002719","article-title":"Metabolism and toxicity of thioacetamide and thioacetamide S-oxide in rat hepatocytes","volume":"25","author":"Hajovsky","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1440-1746.2012.07265.x","article-title":"Attenuation of hepatic fibrosis by an imidazolium salt in thioacetamide-induced mouse model","volume":"28","author":"Ding","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0170","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"CXC chemokine ligand 4 (CXCL4) is a platelet-derived mediator of experimental liver fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0175","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/labinvest.2008.91","article-title":"Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice","volume":"88","author":"Salguero Palacios","year":"2008","journal-title":"Lab. Investig."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2018.08.009_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0023677215573040","article-title":"Standard operating procedures in experimental liver research: Thioacetamide model in mice and rats","volume":"49","author":"Wallace","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2131\/jts.39.785","article-title":"Detection of initiating potential of non-genotoxic carcinogens in a two-stage hepatocarcinogenesis study in rats","volume":"39","author":"Omura","year":"2014","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxlet.2017.09.015","article-title":"An integrative analysis of chemically-induced cirrhosis-associated hepatocarcinogenesis: histological, biochemical and molecular features","volume":"281","author":"Romualdo","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","article-title":"A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer","volume":"23","author":"La Vecchia","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cbi.2017.04.012","article-title":"Commiphora molmol resin attenuates diethylnitrosamine\/phenobarbital-induced hepatocarcinogenesis by modulating oxidative stress, inflammation, angiogenesis and Nrf2\/ARE\/HO-1 signaling","volume":"270","author":"Mahmoud","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0210","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00204-016-1667-1","article-title":"Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice","volume":"90","author":"Braeuning","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695923","article-title":"Animal models as a tool in hepatocellular carcinoma research: a review","volume":"39","author":"Santos","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/351317a0","article-title":"HBx gene of hepatitis B virus induces liver cancer in transgenic mice","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0230","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.1074\/jbc.M309280200","article-title":"Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells","volume":"279","author":"Lee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0235","doi-asserted-by":"crossref","first-page":"70559","DOI":"10.18632\/oncotarget.12372","article-title":"Hepatitis B virus X induces inflammation and cancer in mice liver through dysregulation of cytoskeletal remodeling and lipid metabolism","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0240","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.18632\/oncotarget.6817","article-title":"HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0245","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.75.8.3851-3858.2001","article-title":"Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions","volume":"75","author":"Madden","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0250","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hep.28924","article-title":"Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis","volume":"65","author":"Niu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0255","doi-asserted-by":"crossref","first-page":"69267","DOI":"10.18632\/oncotarget.12121","article-title":"Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0260","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.23747","article-title":"Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha\/phosphoinositide 3-kinase signaling","volume":"52","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0265","doi-asserted-by":"crossref","first-page":"18384","DOI":"10.1073\/pnas.1116386108","article-title":"Depletion of beta-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02256001","article-title":"Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies","volume":"10","author":"Liu","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0275","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.22159","article-title":"Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice","volume":"47","author":"Martinez-Chantar","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12929-016-0278-8","article-title":"Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K\/Akt pathway in the liver","volume":"23","author":"Liao","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0285","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/ijc.30652","article-title":"Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma","volume":"140","author":"Li","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0290","doi-asserted-by":"crossref","first-page":"442","DOI":"10.18632\/oncotarget.23064","article-title":"Utilizing glycine N-methyltransferasegene knockout mice as a model for identification of missing proteins in hepatocellular carcinoma","volume":"9","author":"Yang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/carcin\/bgv156","article-title":"Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress","volume":"37","author":"Tebbi","year":"2016","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-015-1110-z","article-title":"ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression","volume":"51","author":"Degiorgio","year":"2016","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0305","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0310","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0315","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-07-0172","article-title":"Molecular mechanisms of liver carcinogenesis in the Mdr2-knockout mice","volume":"5","author":"Katzenellenbogen","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(\u2212\/\u2212) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30061","article-title":"Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis","author":"Taylor","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0335","doi-asserted-by":"crossref","first-page":"23306","DOI":"10.18632\/oncotarget.4202","article-title":"Mouse models of liver cancer: progress and recommendations","volume":"6","author":"He","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0340","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/ijc.29703","article-title":"Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy","volume":"138","author":"Ju","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059869","article-title":"Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging","volume":"8","author":"Ju","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0350","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1242\/dmm.000976","article-title":"Mouse xenograft models vs GEM models for human cancer therapeutics","volume":"1","author":"Richmond","year":"2008","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0355","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","article-title":"Preclinical mouse cancer models: a maze of opportunities and challenges","volume":"163","author":"Day","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0360","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-16-1260","article-title":"Humanized mouse xenograft models: narrowing the tumor-microenvironment gap","volume":"76","author":"Morton","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0365","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/aps.2017.156","article-title":"Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0370","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15384047.2016.1276132","article-title":"Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model","volume":"18","author":"Lee","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0375","doi-asserted-by":"crossref","first-page":"41242","DOI":"10.18632\/oncotarget.17168","article-title":"Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0380","doi-asserted-by":"crossref","first-page":"84520","DOI":"10.18632\/oncotarget.11731","article-title":"Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0385","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00270-016-1515-y","article-title":"Cinnamic acid derivatives enhance the efficacy of transarterial embolization in a rat model of hepatocellular carcinoma","volume":"40","author":"Wilkins","year":"2017","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0390","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0395","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4254\/wjh.v9.i11.533","article-title":"Hepatocellular carcinoma in non-alcoholic steatohepatitis: current knowledge and implications for management","volume":"9","author":"Cholankeril","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0400","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jceh.2014.12.010","article-title":"Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet","volume":"5","author":"Hamzawy","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0405","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/iep.12240","article-title":"Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet","volume":"98","author":"Ikawa-Yoshida","year":"2017","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-016-0477-5","article-title":"Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine","volume":"16","author":"Kishida","year":"2016","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0420","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0425","doi-asserted-by":"crossref","first-page":"10283","DOI":"10.1038\/s41598-018-28486-8","article-title":"Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma","volume":"8","author":"Henderson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0430","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-319-09614-8_11","article-title":"Alcohol consumption, Wnt\/beta-catenin signaling, and hepatocarcinogenesis","volume":"815","author":"Mercer","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0435","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2017.07.023","article-title":"Animal models of HCC - when injury meets mutation","volume":"68","author":"Yan","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0440","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.6946.1","article-title":"Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances","volume":"5","author":"Dhanasekaran","year":"2016","journal-title":"F1000 Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0445","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1478-3231.2005.01016.x","article-title":"Preneoplastic lesions in human hepatocarcinogenesis","volume":"25","author":"Libbrecht","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0450","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.22709","article-title":"Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia","volume":"49","author":"Kojiro","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2018.08.009_bb0455","doi-asserted-by":"crossref","first-page":"15955","DOI":"10.3748\/wjg.v20.i43.15955","article-title":"Histopathology of hepatocellular carcinoma","volume":"20","author":"Schlageter","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0460","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1293\/tox.25.189","article-title":"Comparative histomorphological review of rat and human hepatocellular proliferative lesions","volume":"25","author":"Thoolen","year":"2012","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0465","first-page":"3918","article-title":"Morphological classification of mouse liver tumors based on biological characteristics","volume":"42","author":"Becker","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.08.009_bb0470","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/carcin\/18.1.59","article-title":"Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment","volume":"18","author":"Grisham","year":"1997","journal-title":"Carcinogenesis"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918302941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:46:20Z","timestamp":1760417180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918302941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0925443918302941"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.009","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}